If anyone is considering filing a complaint to the IIROC
I will gladly join in. The NR is terribly incomplete. No data was provided except a very unexpected MB. No mention of placebo group M, treated group mortality, CM, non-consent group mortality, statistical analysis, the statistical discrepancy (non-consent M 62% vs placebo M 47,5% ??).
No hard data, just a : well it is certainly not for now folks, have a good day.
Also, the IIROC could have halted (maybe they never do, but they should), considering the lack of data provided and the subsequent debacle. The panic sell was a result of a complete loss of confience over Spectral's management, considering what had transpired this summer and at the September conference. I never thought top line data would look like it did. You can DD till the end of time, but if there is bad faith or gross incompetence on the part of the people sharing the data, you can only blindly hope everything is at it is. The trial was botched or something (mixup in canisters) or those in charge failed to monitor the patient composition to control factors : one I might think of is the fact that the non-consent subgroup was composed in a major way of people who had already been admitted for long periods in hospitals and their family did not think they had it in them to survive any treatment, and the randomized group was composed of patients that were unexpectantly admitted to the ICU and their family had a feeling they could benefit from what treatment they could get).
Off crying for now.